317 related items for PubMed ID: 24631042
21. Losartan and enalapril are comparable in reducing proteinuria in children.
Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
[Abstract] [Full Text] [Related]
22. Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial.
Jin D, Huang WJ, Meng X, Yang F, Bao Q, Zhang MZ, Yang YN, Ni Q, Lian FM, Tong XL.
Trials; 2019 Dec 21; 20(1):756. PubMed ID: 31864393
[Abstract] [Full Text] [Related]
23. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.
Wu R, Wei F, Qu L, Bai L, Li J, Li F, Yan W, Wang Q, Wei J.
Trials; 2020 Nov 23; 21(1):951. PubMed ID: 33228726
[Abstract] [Full Text] [Related]
24. Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases: A multicentre, open-label and single-arm clinical trial.
Sun X, Li P, Lin H, Ni Z, Zhan Y, Cai G, Liu C, Chen Q, Wang W, Wang X, Zhang P, Li P, Liang M, Zheng H, Wang N, Miao L, Jin R, Guo Z, Wang Y, Chen X.
Phytomedicine; 2022 May 23; 99():154011. PubMed ID: 35278897
[Abstract] [Full Text] [Related]
25. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
Bianchi S, Bigazzi R, Campese VM.
Am J Kidney Dis; 2010 Apr 23; 55(4):671-81. PubMed ID: 20097461
[Abstract] [Full Text] [Related]
26. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N.
Am J Kidney Dis; 2009 Oct 23; 54(4):647-52. PubMed ID: 19596163
[Abstract] [Full Text] [Related]
27. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M, Okada K, Maruyama T, Matsumoto K.
Pharmacotherapy; 2009 Sep 23; 29(9):1061-72. PubMed ID: 19698011
[Abstract] [Full Text] [Related]
28. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
Gan J, Wu Y, Gong X, Ma Y, Yu S, Gao J.
Trials; 2019 Aug 07; 20(1):481. PubMed ID: 31391092
[Abstract] [Full Text] [Related]
29. Efficacy and safety of Yiqi Peiyuan granules for improving the short-term prognosis of patients with acute kidney injury: A multicenter, double-blind, placebo-controlled, randomized trial.
Wu JJ, Zhang TY, Qi YH, Zhu MY, Fang Y, Qi CJ, Cao LO, Lu JF, Lu BH, Tang LM, Shen JX, Mou S.
J Integr Med; 2024 May 07; 22(3):279-285. PubMed ID: 38688809
[Abstract] [Full Text] [Related]
30. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.
Wang M, Wang Z, Zhou J, Sun W, Wang Y, Han M, Yang H, Liu WJ, Wang Y.
Trials; 2018 Jul 17; 19(1):389. PubMed ID: 30016983
[Abstract] [Full Text] [Related]
31. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
Nephrol Dial Transplant; 2009 Dec 17; 24(12):3694-701. PubMed ID: 19628647
[Abstract] [Full Text] [Related]
32. Aliskiren and losartan trial in non-diabetic chronic kidney disease.
Woo KT, Choong HL, Wong KS, Tan HK, Foo M, Fook-Chong S, Lee EJ, Anantharaman V, Lee GS, Chan CM.
J Renin Angiotensin Aldosterone Syst; 2014 Dec 17; 15(4):515-22. PubMed ID: 24742970
[Abstract] [Full Text] [Related]
33. Renal protective effect and action mechanism of Huangkui capsule and its main five flavonoids.
Cai HD, Su SL, Qian DW, Guo S, Tao WW, Cong XD, Tang R, Duan JA.
J Ethnopharmacol; 2017 Jul 12; 206():152-159. PubMed ID: 28408246
[Abstract] [Full Text] [Related]
34. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M, Tylicki L, Rutkowski P, Rutkowski B.
Scand J Urol Nephrol; 2004 Jul 12; 38(5):427-33. PubMed ID: 15764256
[Abstract] [Full Text] [Related]
35. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
Lambers Heerspink HJ, Tighiouart H, Sang Y, Ballew S, Mondal H, Matsushita K, Coresh J, Levey AS, Inker LA.
Am J Kidney Dis; 2014 Dec 12; 64(6):860-6. PubMed ID: 25441439
[Abstract] [Full Text] [Related]
36. Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled study.
Xie Y, Huang S, Wang L, Miao L, Zhang A, Li Y, Wu X, Wang L, Liu S, Lie C, Chen P, Chen X.
Am J Med Sci; 2011 May 12; 341(5):367-72. PubMed ID: 21293249
[Abstract] [Full Text] [Related]
37. Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial.
Liu LJ, Lv JC, Shi SF, Chen YQ, Zhang H, Wang HY.
Am J Kidney Dis; 2012 Jan 12; 59(1):67-74. PubMed ID: 22019331
[Abstract] [Full Text] [Related]
38. The efficacy of Chinese herbal medicines on acute coronary syndrome with renal insufficiency after percutaneous coronary intervention.
Zhang DW, Wang SL, Wang PL, Du JP, Gao ZY, Wang CL, Xu H, Shi DZ.
J Ethnopharmacol; 2020 Feb 10; 248():112354. PubMed ID: 31689480
[Abstract] [Full Text] [Related]
39. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
Am J Kidney Dis; 2009 Apr 10; 53(4):606-16. PubMed ID: 19216016
[Abstract] [Full Text] [Related]
40. Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease.
Lee YJ, Cho S, Kim SR, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG.
Postgrad Med J; 2011 Oct 10; 87(1032):664-9. PubMed ID: 21715572
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
